Cyagen White Paper: Infectivity and Immune Mechanisms of Coronaviruses & SARS-CoV-2
An outbreak of COVID-19 (Coronavirus Disease in 2019) caused by the novel coronavirus, officially named SARS-CoV-2 , swept across the world from Wuhan at the end of 2019 - having since brought a huge impact on the lives of people both in China and abroad. The World Health Organization’s (WHO) Emergency Committee declared the SARS-CoV-2 outbreak to be a Public Health Emergency of International Concern (PHEIC) on January 30, 2020. In order to effectively address COVID-19 as a public health threat, we need an in-depth understanding of its infection and immune mechanisms. Our experts have investigated the known characteristics of SARS-CoV-2, similarities to related coronaviruses, potential antiviral targets, and lessons learned from the outbreak from a research perspective – which we have assembled to assist in such research efforts. As we know, SARS-CoV uses angiotensin-converting enzyme (ACE2) as a receptor for mediating cell entry and mainly infects epitheli...